The landscape of dementia diagnosis has evolved radically with the appearance of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology a long time prior to indications emerge. Though these technological advances stand for impressive progress in understanding neurodegenerative ailments, they have https://mildcognitiveimpairmenttr77665.blogdosaga.com/38011519/the-enduring-price-of-cognitive-evaluation-for-older-older-people